Neurodegenerative Diseases
On this page:
Neurodegenerative diseases
Neurodegenerative diseases are a group of disorders in which brain and nervous system cells progressively degenerate and die. These diseases affect the functions of the brain and nervous system, which can lead to changes in behavior, memory, movement, and coordination.
Some of the most common neurodegenerative diseases include Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). These diseases are chronic, progressive, and incurable, and can have a major impact on the quality of life of the individual and their families.
Although the exact causes of neurodegenerative diseases are not known, it is believed that a combination of genetic and environmental factors may increase the risk of developing these diseases. Early diagnosis and appropriate treatment can improve the quality of life for people affected by these diseases.
Research and development of new treatments for neurodegenerative diseases are active areas of research worldwide, and significant advances in understanding and treating these diseases are expected in the future.
Alzheimer's disease
Alzheimer’s is a disease that affects a large number of people worldwide. In Spain, according to data from the Spanish Society of Neurology, it is estimated that around 800,000 people have Alzheimer’s or some other form of dementia, and this figure is expected to increase as the population ages.
Alzheimer’s disease is the most common cause of dementia in people over 65 years of age, and it is estimated that between 60% and 70% of people with dementia have Alzheimer’s. In addition, the disease is believed to affect women more often than men.
Globally, the World Health Organization (WHO) estimates that around 50 million people have dementia, and this figure is expected to increase as the population ages. The WHO also estimates that Alzheimer’s disease and other forms of dementia are responsible for 10% of all deaths worldwide.
Alzheimer’s disease mainly affects people over 65 years of age. The disease is characterized by a progressive loss of memory and other cognitive skills, which can significantly affect a person’s ability to perform daily activities.
Although the exact cause of Alzheimer’s disease is not yet known, it is believed that a combination of genetic and environmental factors may increase the risk of developing the disease.
Treatments for Alzheimer’s disease may include medications to improve cognitive function, occupational therapy, and speech and language therapy to help the person maintain their independence and ability to perform daily activities. Specialized medical care and appropriate rehabilitation are essential to improve the quality of life for people with Alzheimer’s disease and their caregivers.
It is important to note that Alzheimer’s disease is a chronic and progressive disease, and that long-term care and attention are essential to ensure an adequate quality of life for the affected person and their family.
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a rare and serious neurological disease that affects the nerve cells responsible for controlling the body’s muscles. In Spain, according to the Spanish Federation of Neurological Diseases, it is estimated that around 4,000 people have ALS at any given time.
ALS can affect people of all ages, but it is more common in people over 40 years of age. In addition, the disease is believed to affect men more often than women.
Worldwide, ALS affects around 2 people per 100,000 inhabitants, and it is estimated that there are around 450,000 people living with the disease worldwide.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord that control muscle movements. The disease is characterized by a progressive degeneration of these nerve cells, which can lead to muscle weakness, difficulty speaking, swallowing, and breathing, and other symptoms.
The symptoms of ALS can vary from person to person, but usually include muscle weakness, muscle spasms, coordination and balance problems, difficulty speaking and swallowing, and difficulty breathing.
Although there is no cure for ALS, there are treatments that can improve the quality of life of the affected person. Treatments may include medications to improve muscle and respiratory function, occupational and speech therapy to improve the person’s ability to perform daily activities, and physical therapy to improve muscle strength and coordination.
Friedreich's ataxia
Friedreich’s Ataxia is a rare inherited disease that affects the nervous system and can cause problems with balance, coordination, and speech. In Spain, according to the Spanish Federation of Ataxias, it is estimated that around 400 people have Friedreich’s Ataxia.
The disease can affect people of all ages, but usually manifests in childhood or adolescence. Friedreich’s Ataxia is inherited in an autosomal recessive manner, which means that both parents must carry the defective gene for the child to inherit the disease.
Worldwide, it is estimated that Friedreich’s Ataxia affects around 1 person per 50,000 inhabitants. The disease is more common in people of European descent, although it can affect people of any race or ethnicity.
Friedreich’s ataxia is a hereditary and progressive neurological disease that affects the brain and peripheral nervous system. The disease is characterized by a progressive degeneration of sensory and motor nerves, which can lead to problems with balance, coordination, and movement.
Friedreich’s ataxia is caused by a mutation in a specific gene, which interferes with the production of a protein necessary for the normal functioning of nerve cells. The disease is transmitted in an autosomal recessive manner, which means that a child must inherit a copy of the mutated gene from each of their parents to develop the disease.
The symptoms of Friedreich’s ataxia can vary from person to person, but usually include problems with balance and coordination, difficulty walking, muscle weakness, decreased sensitivity in the extremities, and other symptoms. The disease can progress over time and can lead to disability.
Currently, there is no cure for Friedreich’s ataxia, but there are treatments that can improve the quality of life of affected individuals. Treatments may include physical and occupational therapy to improve mobility and the ability to perform daily activities, and medications to treat specific symptoms of the disease.
It is important to note that specialized medical treatment and care can significantly improve the quality of life for people with Friedreich’s ataxia and their families.
Parkinson's disease
Parkinson’s is a chronic neurodegenerative disease that affects the brain and central nervous system. The disease is characterized by a progressive loss of nerve cells that produce dopamine, which can lead to tremors, muscle stiffness, balance and coordination problems, and other symptoms.
In Spain, according to data from the Spanish Society of Neurology, it is estimated that around 160,000 people have Parkinson’s.
Parkinson’s disease is more common in people over 60 years of age, and it is believed to affect men more often than women. In addition, it is estimated that the prevalence of Parkinson’s disease worldwide is 1% in people over 60 years of age.
Worldwide, Parkinson’s disease is one of the most common neurodegenerative diseases, and it is estimated that around 6.1 million people have the disease worldwide. This figure is expected to increase as the population ages.
Rehabilitation can play an important role in the treatment of Parkinson’s, as it can help improve a person’s ability to perform daily activities and maintain independence. Rehabilitation programs may include physical therapy to improve muscle strength and coordination, occupational therapy to improve a person’s ability to perform daily activities, and speech and language therapy to improve communication.
In addition to rehabilitation, there are medical treatments that can improve the symptoms of Parkinson’s. These treatments may include medications to improve dopaminergic function, deep brain stimulation therapy to help control motor symptoms and depression, and other specific treatments.
Spinal muscular atrophy
Spinal muscular atrophy (SMA) is a hereditary neuromuscular disease that affects nerve cells in the spinal cord and muscles of the body.
The disease is characterized by a progressive degeneration of the nerve cells that control the muscles, which can lead to muscle weakness, difficulty walking, breathing, and swallowing, and other symptoms.
There are several types of SMA, which are classified according to the age of onset of symptoms and the severity of the disease. SMA type 1 is the most severe form of the disease and can lead to serious respiratory problems and a reduced life expectancy. SMA type 2 is less severe and can lead to muscle weakness and difficulties walking and sitting. SMA type 3 is the mildest form of the disease and can lead to muscle weakness and coordination problems.
In Spain, according to the Spanish Federation of Neuromuscular Diseases, it is estimated that around 400 people have SMA at any given time.
SMA can affect people of all ages, but it is more common in infants and young children. In addition, the disease is believed to affect men and women equally.
Worldwide, it is estimated that SMA affects around 1 person per 10,000 to 20,000 inhabitants. The disease can be of different types, depending on the age of onset and the severity of the symptoms.
Currently, there is no cure for SMA, but there are treatments that can improve the quality of life of affected individuals. Treatments may include physical therapy to improve muscle strength and coordination, occupational therapy to improve a person’s ability to perform daily activities, and other specific treatments according to the needs of each person.